SEMINARS IN ARTHRITIS AND RHEUMATISM, cilt.46, sa.4, ss.529-535, 2017 (SCI-Expanded)
Objective: Our aim was to describe our experience with tocilizumab (interleukin 6 receptor antagonist) treatment in children with Takayasu arteritis and to review previous studies regarding tocilizumab use in Takayasu arteritis patients.